U‑Blox and KPN Settle Patent Dispute And Sign Patent License Agreement

Recently, U‑Blox AG and U-blox America Inc. (“u-blox”), announced that it has entered into a worldwide, non-exclusive, patent license agreement with Koninklijke KPN N.V., (“KPN”), for a defined term while settling their ongoing patent disputes. The patent license agreement covers the sale of u‑blox products and services that KPN believes to be essential for telecommunication standards. Patent infringement […]

Advantages of Patent Valuation

Patents are the core asset generator for various industries. Industries and companies earn a lot through licensing and assigning patents. The license and assignment of patents are common practices in the market which makes the licensor earn millions of royalties. With the rapid technology development and increasing users around the world, the trends of licensing […]

Sun Pharma and Celegene Settle Patent Dispute over Lenalidomide (Revlimid®)

Settling an over three old patent infringement dispute, Indian pharmaceutical major, Sun Pharmaceuticals and its subsidiary, including US subsidiary (“Sun”), has reached a settlement with Celgene Corporation (“Celgene”), a subsidiary of pharmaceutical major Bristol Myers Squibb (BMS), to resolve and settle the patent litigation regarding submission of an Abbreviated New Drug Application (ANDA) for a […]